We’re delighted to share that IHRI held its second CAG meeting, reaching a consensus to expand beyond recruitment to engagement across the clinical trial lifecycle - tackling mistrust, power gaps, and legal barriers, and seeking to uncover the truth behind public disengagement.
Our team will be actively presenting at #ESCMID2026 showcasing key work in antimicrobial resistance (AMR), Gram-negative infections, and innovative clinical trial approaches.
📍 Join us from 17–21 April 2026 to connect, learn, and engage with us: ad-id.co/escmid26
On 12 February 2026, the ADVANCE-ID team had the opportunity to visit Clinical Research Malaysia (CRM) in Kuala Lumpur — a key driver of Malaysia’s growing clinical trial ecosystem.
Read more: www.linkedin.com/feed/update/...
✨Invitation to join our ADVANCE-ID Seminar Series!
Join us for an upcoming online seminar on 23 Feb 2026 (5-6pm SGT), featuring our project updates and a time of discussion on collaboration opportunities in the future direction of ADVANCE-ID.
🔗Register here: ad-id.co/s1
@who.int will be running a soft launch of the online course for clinical trials - March 2026 🚀
Clinical research learners are invited to:
✅ Early course access
💬 Interactive learning
📝 Share feedback
🌍 Become course ambassadors
EOI deadline: 15 Feb 2026
🔗 ad-id.co/whoct
⏰One week to go until #ACC2026!
From early antibiotic discovery to real-world clinical use and access, ACC2026 brings together global expertise for 2 days of focused discussion, live Q&A and shared learning.
📅 4–5 Feb 2026 I🌍Free and Online
🔗 Register now: https://eventsair.pulse.ly/lvlg78hsiq
🚀 ACC2026 is coming up soon
This free, global, online conference brings together leading minds and experts to explore what’s next for antimicrobial chemotherapy.
Co-organized by GARDP and BSAC
📅 4–5 Feb 2026 |🌍 Online
🔗 Register now: bit.ly/4pSEdt7
@bsacandjac.bsky.social @advance-id.bsky.social
📢 Your experience matters — help us enhance lab capacities!
Please take the survey and share it with other institutions/hospitals, whether or not they have microbiology labs.
Link to survey: lnkd.in/gpv3fJka
📱 You can also scan the QR code to participate
On 15 Jan 2026, @gardp.bsky.social will host a online webinar on “5 BY 25”, its 5-year initiative focused on advancing antimicrobial R&D and access.
Prof David Paterson will be part of the conversation.
⏰ 16:30-17:30 IST/13:00-14:00 SAST/ 19:00-20:00 GMT+8
Register here: ad-id.co/4pp1PFj
#AMR
We are growing our team! Join us as a Research Associate and support regional efforts to strengthen community engagement in clinical trials: ad-id.co/4junN8t
#WeAreHiring #ClinicalTrials #CommunityEngagement #ResearchAssociate #ADVANCE_ID
✨ We’re are pleased to introduce Mrs Tin Tin Win Aye and welcome her to the ADVANCE-ID team! Learn more about her in this brief profile.
#WelcomeOnboard #ADVANCE_ID #AMR #ClinicalTrials #Research #Singapore
Registrations are open for ACC2026, a free, 2-day online conference on the latest advances in antimicrobial research.
Organised by GARDP & BSAC, with collab partners ADVANCE-ID & Mahidol University.
📆 4–5 Feb 2026
🔗 https://bit.pulse.ly/qmgpewgvig
@bsacandjac.bsky.social I @advance-id.bsky.social
💻 GARDP is hosting a webinar on the progress & lessons from 5 BY 25, our multi-year effort to advance new antibiotic treatments that address innovation & access gaps.
📅15 Jan 2026⏰12:00–13:00 CET
We'll share key results & what's needed for sustainable innovation.
🔗https://bit.pulse.ly/bmwkjrlg2h
On 8 and 9 December, ADVANCE-ID hosted the REACH Asia Online Forum, bringing together experts to discuss the importance of engaging communities for clinical trials.
Read more: ad-id.co/4pvjX17
Last week, the ADVANCE-ID team had the opportunity to visit Rumah Sakit Nasional Dr. Cipto Mangunkusumo, #OUCRU #Indonesia, and the Indonesia Clinical Research Center (INA-CRC) teams in #Jakarta.
🔗Read more: ad-id.co/3XGzRcR
#ClinicalTrials #collaborate @oucru.bsky.social
We're delighted to share that the our Thai Public Engagement Hub led by the Institute of HIV Research and Innovation (IHRI), Thailand successfully conducted its first Community Advisory Group meeting for the Promoting Community Engagement in Clinical Trials in Asia project.
🔗 ad-id.co/4rwS0aL
✨ We’re are pleased to introduce Mr Huang Xiangyuan and welcome him to the ADVANCE-ID team! Learn more about him in this brief profile.
#WelcomeOnboard #ADVANCE_ID #AMR #ClinicalTrials #Research #Singapore
🏆 Dr Mo Yin, Deputy Director of ADVANCE-ID, has been awarded the L’Oréal-UNESCO For Women in Science Award 2025 (Singapore)! 👩🔬✨ “AMR is a silent pandemic, and this recognition reinforces the urgency of rigorous science.” 👏
🔗 Find out more: ad-id.co/4oeORte
#WomenInScience #AMR #NUS #Research
CARB-X has released updated eligibility criteria for 2025 Funding Round (opens from 1–12 Dec): therapeutics for Gram‑negative infections and Diagnostics for Salmonella Typhi for low resource settings
Join webinars on 4–5 Dec.
Find out more: ad-id.co/c1
@carb-x.bsky.social
#AMR #GlobalHealth
✨ We’re are pleased to introduce Dr Xiao Tingting and welcome her to the ADVANCE-ID team! Learn more about her in this brief profile.
#WelcomeOnboard #ADVANCE_ID #AMR #ClinicalTrials #Research #Singapore
Join us on 8–9 Dec 2025 for the REACH Asia Forum on Community Engagement! Hear from experts and community leaders across the region on strengthening community engagement and participation in health research.
Register at 🔗https://ad-id.co/reach2025
#CommunityEngagement
We’re delighted to share highlights from our recent workshop “Framing JUST solutions for ACCESS to treatment against AMR”! Fantastic participants, candid challenge-sharing, and lively, solutions-focused discussions throughout the day.
Read more: ad-id.co/4qMQMb1
🧪 Share Your #AMR Research at #ACC2026 now! Abstract Submission Open Until 14 Nov 2025.
Organized by @gardp.bsky.social , @bsacandjac.bsky.social , @advance-id.bsky.social & Mahidol University.
🗓 Submission deadline: Friday, 14 Nov 2025
🔗 Submit your abstract: lnkd.in/dBfh3zWJ
#AbstractSubmission
New research led by Dr Mo Yin from ADVANCE-ID (NUS) finds that some individuals can carry multidrug-resistant E. coli for extended periods and at high amounts, potentially spreading it.
Find out more:
Lianhe Zaobao: ad-id.co/3Jtm9GO
NUS Medicine: ad-id.co/3LclQ3H
What do you think are the overlooked priorities in antimicrobial resistance mitigation strategies? Share your top 3:
Link: forms.office.com/r/CP81tasyRX
⏱ Takes <3 minutes
@ttu.edu #GodwinPiusOhemu
👩💻 How can #AI transform microbiology?
Join Adrian Egli & Javier Fernández Domínguez at our next #REVIVE webinar to take a closer look at how AI is being used to analyse microbiological data and predict antimicrobial susceptibility.
📅 28 Oct | 17:00 CET
🔗 Register: bit.ly/42nlm0q
Proud to join @who.int ’s new GCTF to advance equitable, ethical & impactful research worldwide. Together with NUS SSHSPH, ADVANCE-ID will help strengthen Asia’s trial ecosystems - training local teams, innovating designs & fostering collaboration.
🔗 Read more: ad-id.co/GCTF
NUS Medicine has received a co-funded gift of S$2 million from the Novo Nordisk Foundation and Temasek Foundation to support DETECT-Asia (Strengthening Diagnostics for sEvere bacTErial infeCTions in Asia) to enhance the #diagnostics for severe bacterial infections and fight #AMR. ad-id.co/gpr
ADVANCE-ID Directors make presentations at the inaugural Global AMR Innovators Conference (GAMRIC), London, October 1 and 2, 2025.
Read more: ad-id.co/a1
#GAMRIC2025
💭 How do we make the most of the funding that we have available for #AMR? Innovation AND evaluation of impact. Development AND implementation in real life have to be thought at the same time.
#GAMRIC2025 @carb-x.bsky.social @lifearc.bsky.social @gardp.bsky.social @advance-id.bsky.social #IDSky